DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 3 filers reported holding DIPLOMAT PHARMACY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,000 | -42.9% | 11,934 | -30.2% | 0.01% | -46.7% |
| Q3 2019 | $84,000 | -65.0% | 17,086 | +38.4% | 0.02% | -54.5% |
| Q3 2018 | $240,000 | -25.5% | 12,343 | -23.2% | 0.03% | -42.1% |
| Q4 2017 | $322,000 | -47.2% | 16,062 | -61.0% | 0.06% | -50.4% |
| Q2 2017 | $610,000 | +122.6% | 41,233 | +322.2% | 0.12% | +57.5% |
| Q3 2016 | $274,000 | – | 9,766 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |